Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Showa Yakuhin to market CollaGenex's Periostat in Japan

Aug. 11, 2000

Study shows xylitol chewing gum is effective against oral bacteria

Aug. 2, 2000

Atrix receives Canadian marketing approval for Atridox

July 11, 2000

Periodontix and PPL Therapeutics successfully complete feasibility study for transgenic P-113

June 20, 2000

Taiho discovers naturally occurring substance with potential in periodontal diseases

May 12, 2000

CollaGenex files new MAA, enters marketing agreement for Periostat tablets

May 8, 2000

OraPharma's NDA for MPTS accepted for FDA review

April 27, 2000

Periodontix tests sustained silver delivery for periodontitis

April 13, 2000

Periodontix's histatin mouthrinse reduces plaque and gingivitis

April 12, 2000

CollaGenex research reported at international dental meeting

April 11, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...